Professional product catalogue
Constipation
The Constipation category brings together laxative medicines and presentations assigned to this bowel-function disorder. Constipation may involve stool frequency, consistency or difficulty passing stools, which are distinct dimensions. Families differ through action and pharmaceutical form, with oral and rectal preparations using different designs. It helps explain terminology used in pharmacy without confusing a laxative medicine with a dietary fibre product or a preparation intended for another digestive procedure, even where similar words appear in their descriptions.
Products in this category
138 products
Arrow Génériques
BISACODYL ARROW CONSUMER 5 mg Gastro-resistant tablet Blister pack/30
CIP / EAN : 3400930131831
EG LaboBISACODYL EG LABO CONSEIL 5 mg Coated Gastro-resistant Tablet PVC/alu Blister/30
CIP / EAN : 3400930088395
Viatris SantéBISACODYL VIATRIS OTC 5 mg Gastro-resistant coated tablet blister/30
CIP / EAN : 3400930088524
Coopération Pharmaceutique FrançaiseCRISTAL Children's suppositories 10Sachet
CIP / EAN : 3400933195878
Coopération Pharmaceutique FrançaiseDUPHALAC 10 g/15 ml S buv en sachet 20Sach/15ml
CIP / EAN : 3400927693199
Coopération Pharmaceutique FrançaiseDUPHALAC 66,5 % S buv en flacon Fl/200ml
CIP / EAN : 3400935235145
Understanding constipation
Understanding laxative families
Osmotic laxatives promote the presence of water in stools. Bulk-forming laxatives use substances that increase the volume of intestinal contents. Stimulants act on motility, while other preparations have a lubricating or local action. These terms describe mechanisms rather than a simple scale from a weak product to a strong one. A precise description therefore retains the pharmacological family instead of relying only on the general phrase bowel function, which can encompass several different processes and types of product.
Oral and rectal presentations
Powders requiring preparation, solutions, tablets and suppositories represent different pharmaceutical approaches. In a sachet preparation, the mass of powder is not necessarily the amount of a single active ingredient. Combinations may include several components, including electrolytes in certain formulations. Rectal preparations have their own route and presentation characteristics. Product consistency, any preparation required and complete composition provide useful information when a pharmacy team identifies a medicine, particularly when similar packaging covers preparations with different pharmaceutical purposes.
Distinguishing medicines from nutrition
Dietary fibres, food supplements and laxative medicines do not all share the same regulatory status. Similar wording on a pack is insufficient to combine them into one type of product. Constipation treatment also needs to remain distinct from certain bowel preparations used in the context of an examination. Clinical context and the individual medicine specify that purpose. Mechanism, route and formulation consequently provide complementary properties without making every presentation or regulatory product type equivalent in function or pharmaceutical characteristics.
Frequently asked questions
Are osmotic and stimulant laxatives the same?
No. The terms relate respectively to water within intestinal contents and to motility. They identify different families with their own documented characteristics.
Is a fibre-rich product necessarily a medicine?
No. Fibre can be part of food, a supplement or a bulk-forming medicine. Regulatory status and the complete presentation establish the distinction.
Updated 10 November 2026
Sources and further reading






